Point of Care Molecular Diagnostics Market by Product & Service (Assays, Kits, Analyzers, Software), Application (Respiratory Disease, Hospital Acquired Infection), Technology (RT-PCR, INAAT), End User (Physician Office, ICUS) - Global Forecast to 2023
“The global POC molecular diagnostics market is projected to grow at a CAGR of 14.7%.”
The global point of care (POC) molecular diagnostics market is expected to reach USD 1440.2 million by 2023 from USD 725.5 million in 2018, at a CAGR of 14.7%. Growth in the POC molecular diagnostics market is driven by the increasing prevalence of infectious diseases, rising focus on decentralized diagnostics, and the growing demand for CLIA-waived molecular POC tests. However, inadequate reimbursement and stringent regulatory policies are likely to restrain the growth of this market during the forecast period.
“The INAAT technology is expected to grow at highest CAGR during the forecast period.”
Based on technology, the POC molecular diagnostics market is segmented into RT-PCR, INAAT, and other technologies. The INAAT segment is expected to grow at highest CAGR during the forecasted period. The increasing popularity of INAAT for infectious diseases diagnosis is expected to drive this market in the coming years.
“Asia Pacific is projected to grow at the highest CAGR during the forecast period.”
While North America is expected to account for the largest share of the global POC molecular diagnostics market, Asia Pacific is projected to grow at the highest CAGR during the study period. The key factors influencing the growth of this market include growing initiatives by market players, rising demand for influenza A/B tests, decentralized healthcare delivery systems, and increasing patient population base in this region.
Break-up profile of primaries:
By Company Type- Tier 40%, Tier 30%, and Tier 30%
By Designation-C-level-27%, D-level-18%, and Others-55%
By Region-North America-50%, Europe-20%, Asia Pacific-20%, and RoW-10%
The key players in the global POC molecular diagnostics market are Roche Diagnostics (Switzerland), Abbott Laboratories (US), Danaher (US), Biomerieux (France), and Meridian Biosciences (US)
The POC molecular diagnostics market in this report is segmented by product & service, application, technology, end user, and region. The study tracks and analyzes competitive developments such as product launches & approvals, acquisition, collaborations, agreements, partnerships, and expansion, and profiles key players and their core competencies in the POC molecular diagnostics market.
Reasons to buy this report:
The report provides insights on the following pointers:
Market Penetration: Comprehensive information on portfolios offered by the top players in the global POC molecular diagnostics market. The report analyzes the market by product & service, application type, technology, end user, and region
Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and product launches in the global POC molecular diagnostics market
Market Development: Comprehensive information about lucrative emerging markets—the report analyzes the markets for POC molecular diagnostic products across regions
Market Diversification: Exhaustive information about new products, untapped geographies, and recent developments in the global POC molecular diagnostics market
Competitive Assessment: In-depth assessment of strategies, products, and manufacturing capabilities of the key players in the global POC molecular diagnostics market
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.Download eBook